NCT03590327View on ClinicalTrials.gov

Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
ApathyMild Cognitive ImpairmentTranscranial Magnetic StimulationLonelinessCOVIDNeuropsychiatric Symptoms
Interventions
DEVICE

Transcranial Magnetic Stimulation

rTMS

Trial Locations (1)

72205

Central Arkansas Veterans Healthcare System , Little Rock, AR, Little Rock

All Listed Sponsors
collaborator

Central Arkansas Veterans Healthcare System

FED

collaborator

University of Arkansas

OTHER

lead

VA Office of Research and Development

FED

NCT03590327 - Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter